Sol-Gel Technologies (SLGL) Return on Sales Growth (3y) (2021 - 2025)

Sol-Gel Technologies (SLGL) Return on Sales Growth (3y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 0.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 0.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 0.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Sol-Gel Technologies 227.58 Mn 217.44 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 420.00
Sep 30, 2025 -2.00
Jun 30, 2025 1.00
Mar 31, 2025 9.00
Dec 31, 2024 -202.00
Sep 30, 2024 -1.00
Jun 30, 2024 -8.00
Dec 31, 2023 -116.00
Sep 30, 2023 -25.00
Jun 30, 2023 -18.00
Dec 31, 2022 -498.00
Sep 30, 2022 -16.00
Jun 30, 2022 -1.00
Mar 31, 2022 -1.00
Dec 31, 2021 6,481.00
Sep 30, 2021 -202.00
Jun 30, 2021 -140.00
Mar 31, 2021 -124.00